Non-Tariff Barriers

Complaint

Complaint number

NTB-000-714  

NTB Type

6.7. Other  

Complaint

TFDA registers injectables as per pack size and treats each product by itself rendering retaining licences for the product very expensive.  

Status note

During the meeting of the NTBs Focal Points held on 19- 21 August 2019, Tanzania reported that the Bilateral meeting between Kenya and Tanzania held in December 2018, agreed that each country should to continue charging their domestic fees until when the process of harmonization is completed. Immediate implementation. The meeting called on the EAC Secretariat to facilitate the harmonization of food safety standards in the region.  

Progress update note

1. At the 21st meeting of the EAC Regional Forum on NTBs, Tanzania undertook to investigate and report back.
2. During the Bilateral meeting held in December 2018, Tanzania reported that PSSs should instruct that the Issues related to TFDA be discussed by the EAC Standards Committee where food and drug authorities are members to advice if these are NTBs and resolve them. The Meeting recommended that the Task Force established by the Standards Committee should analyse all the fees and charges applicable to food, drugs and cosmetics and make appropriate recommendations by March 2019.  

Policy or regulatory NTB

Yes 

Location

Tanzania: Tanzania Food and Drug Authority (Government institution)  

Reporting Country or Region

Kenya  

Country specific trade issue

No  

Date of incident

2016-06-30  

Status

Resolved  

Date of resolution

2019-08-21  

Product Description

Injections

Computer-assisted translation

• English
• Arabic
• French
• Portuguese

×

Close window

 

Total value

0  

Date reported

2016-07-13 13:37  

Modified

2019-08-21 21:26